EmendoBio: Anocca & EmendoBio Team Up for Next-Gen Cell Therapy
Anocca to integrate EmendoBio's nuclease into its manufacturing process to accelerate the manufacture and development of TCR-T cell therapies.
Read full article »
Emendo is a biotechnology company that develops and commercializes gene-editing therapeutics for the treatment of genetic diseases.
Read more